Learn and develop with our free events, training and resources.
Through research, we work harder and smarter to find more life-saving breakthroughs. Through our campaigning, we make as much noise as possible to bring about change. Through expert support from dedicated nurses, we are here for people affected by pancreatic cancer.
Right now, 7 in 10 people with pancreatic cancer are told there is no treatment available for them. Their chance of survival is taken away. That’s because for decades, governments neglected pancreatic cancer research.
If you want to know more about pancreatic cancer symptoms, we can help.
No question is too tough for Lisa. Call our free Support Line on 0808 801 0707.
With your help, we find the breakthroughs that help detect earlier and treat better.
With your help, we find the breakthroughs that help detect earlier and treat better.
Learn and develop with our free events, training and resources.
With your help in 2024/2025:
We have invested
in research grants in 2024/25 and £1.3M in research support
We have provided
people with direct support - up 6% from the previous year
We have seen
people access our online information and support pages
Help raise money to fund life-saving research, life-changing support and world-changing campaigning.
Give a one-off or regular gift and you can help bring more than hope to thousands of people.
Join our passionate campaigning community and fight for early detection and better treatment.
3 June 2026
Today marks the launch of our Demand Survival Now petition, calling on governments across the UK to fund more research for treatment breakthroughs
31 May 2026
Our comment on daraxonrasib results and the promising group of therapies known as KRAS inhibitors.
31 May 2026
A closer look at a promising group of treatments known as KRAS inhibitors these aim to treat cancers with a mutation in the KRAS gene.
3 June 2026
Today marks the launch of our Demand Survival Now petition, calling on governments across the UK to fund more research for treatment breakthroughs
31 May 2026
Our comment on daraxonrasib results and the promising group of therapies known as KRAS inhibitors.
31 May 2026
A closer look at a promising group of treatments known as KRAS inhibitors these aim to treat cancers with a mutation in the KRAS gene.
